Specialty Pharmaceuticals

Our Salix products

Salix Pharmaceuticals is a specialty pharmaceutical company committed to offering innovative treatments in gastroenterology, endocrinology, and other conditions.

For more than 25 years, we have licensed, developed, and marketed innovative products to provide healthcare professionals and patients with effective solutions for the management of some of the most chronic and debilitating conditions. Salix currently markets its product line through dedicated, specialty sales groups to U.S. healthcare providers in the areas of gastroenterology, hepatology, colorectal surgery, endocrinology, internal medicine, primary care, infectious disease, allergy/immunology, and pediatric urology.

GI disorder treatments

APRISO® (mesalamine) 0.375 g extended-release capsules

Prescribing Information

COLAZAL® (balsalazide disodium) 750 mg capsules

Prescribing Information

GIAZO® (balsalazide disodium) 1.1 g tablets

Prescribing Information

METOZOLV® ODT (metoclopramide HCl) 5 mg orally disintegrating tablets

Prescribing Information, including BOXED WARNING

PEPCID® (famotidine) for oral suspension

Prescribing Information

RELISTOR® (methylnaltrexone bromide) subcutaneous injection

Prescribing Information

RELISTOR® (methylnaltrexone bromide) tablets

Prescribing Information

SOLESTA® (hyaluronic acid/dextranomer)

Prescribing Information

UCERIS® (budesonide) 9 mg extended-release tablets

Prescribing Information

UCERIS® (budesonide) 2 mg rectal foam

Prescribing Information

XIFAXAN® (rifaximin) 550 mg tablets

Prescribing Information

XIFAXAN® (rifaximin) 200 mg tablets

Prescribing Information

ZEGERID® (omeprazole/sodium bicarbonate) capsule and powder

Prescribing Information

Screening preps

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) 100 g/7.5 g/2.691 g/1.015 g/5.9 g/4.7 g for oral solution

Prescribing Information

OSMOPREP® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) tablets

Prescribing Information, including BOXED WARNING

Other Salix products

ANUSOL®-HC (hydrocortisone) 2.5% cream

Prescribing Information

ANUSOL®-HC(hydrocortisone acetate) 25 mg suppository

Prescribing Information

PROCTOCORT® (hydrocortisone) 1% cream

Prescribing Information

PROCTOCORT® (hydrocortisone acetate) 30 mg suppository

Prescribing Information

AZASAN® (azathioprine) 75/100 mg tablets

Prescribing Information, including BOXED WARNING

CYCLOSET® (bromocriptine mesylate) 0.8 mg tablets

Prescribing Information

DIURIL® (chlorothiazide) 250 mg oral suspension

Prescribing Information

DEFLUX® (hyalouronic acid/dextranomer)

Prescribing Information

FENOGLIDE® (fenofibrate) 120 mg & 40 mg tablets

Prescribing Information

GLUMETZA® (metformin) 500 mg & 1000 mg tablets

Prescribing Information, including BOXED WARNING

RUCONEST® (C1 esterase inhibitor [recombinant]) for intravenous use

Prescribing Information

The information contained on this page is intended for US residents, healthcare providers, and pharmacists only.

Apriso is a trademark of Salix Pharmaceuticals or its affiliates.

Azasan is a trademark of AAIPharma Services Corp. used under license.

Colazal is a trademark of Salix Pharmaceuticals or its affiliates.

Cycloset is a registered trademark of VeroScience LLC, Tiverton, RI 02878 used under license

Deflux is a registered trademark of Galderma S.A. used under license.

Diuril is a registered trademark of Merck Sharp & Dohme Corp.

Fenoglide is a trademark of Salix Pharmaceuticals or its affiliates.

Giazo is a trademark of Salix Pharmaceuticals or its affiliates.

Glumetza - is a registered trademark of VeroScience LLC, Tiverton, RI 02878 used under license

Metozolv is a trademark of Salix Pharmaceuticals or its affiliates.

MoviPrep is a trademark of Velinor AG used under license.

OsmoPrep is a trademark of Salix Pharmaceuticals or its affiliates.

Pepcid is a trademark of Johnson & Johnson used under license.

Relistor is a trademark of Salix Pharmaceuticals or its affiliates.

Ruconest is a registered trademark of Pharming Intellectual Property B.V. used under license.

Solesta is a registered trademark of Galderma S.A. used under license.

UCERIS is a trademark of Salix Pharmaceuticals or its affiliates.

UCERIS is a trademark of Salix Pharmaceuticals or its affiliates.

The Xifaxan 550 mg product and the Xifaxan trademark are licensed by Alfa Wassermann S.p.A. to Salix Pharmaceuticals or its affiliates.

The Xifaxan 200 mg product and the Xifaxan trademark are licensed by Alfa Wassermann S.p.A. to Salix Pharmaceuticals or its affiliates.

Zegerid is a trademark of Salix Pharmaceuticals or its affiliates.

Order Product Literature Check out our latest Press Releases and News